Search research articles
Contact Us
Filters
Showing results (41-50 of 57) with videos related to
Page
of 6
Sort By:
Cellular and Molecular Gastroenterology and Hepatology
|
August 19, 2021
SYK-3BP2 Pathway Activity in Parenchymal and Myeloid Cells Is a Key Pathogenic Factor in Metabolic Steatohepatitis
Carmelo Luci, Elodie Vieira, Manon Bourinet, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
December 30, 2024
Disrupting USP39 deubiquitinase function impairs the survival and migration of multiple myeloma cells through ZEB1 degradation
Jessy Sirera, Saharnaz Sarlak, Manon Teisseire, et al.
The Journal of Experimental Medicine
|
September 28, 2011
The p.Arg63Trp polymorphism controls Vav1 functions and Foxp3 regulatory T cell development
Céline Colacios, Audrey Casemayou, Anne S Dejean, et al.
Plos One
|
August 23, 2012
The epithelial-mesenchymal transition (EMT) regulatory factor SLUG (SNAI2) is a downstream target of SPARC and AKT in promoting melanoma cell invasion
Nina Fenouille, Mélanie Tichet, Maeva Dufies, et al.
Iscience
|
February 25, 2025
Evolutionary conserved regulation of TFEB stability by the E3 ubiquitin ligase WWP2 modulates response to stress <i>in vivo</i>
Juan A Garcia-Sanchez, Estelle Bonnet, Céline Loubatier, et al.
Cancer Research
|
May 3, 2022
Secretion of IL1 by Dedifferentiated Melanoma Cells Inhibits JAK1-STAT3-Driven Actomyosin Contractility of Lymph Node Fibroblastic Reticular Cells
Christopher Rovera, Ilona Berestjuk, Margaux Lecacheur, et al.
Cancer Research
|
March 11, 2010
Targeting cancer cell metabolism: the combination of metformin and 2-deoxyglucose induces p53-dependent apoptosis in prostate cancer cells
Issam Ben Sahra, Kathiane Laurent, Sandy Giuliano, et al.
Human Pathology
|
August 8, 2016
Defining a new aggressiveness classification and using NFATc1 localization as a prognostic factor in cherubism
Natacha Kadlub, Quentin Sessiecq, Linda Dainese, et al.
Cell
|
December 14, 2011
Loss of Tankyrase-mediated destruction of 3BP2 is the underlying pathogenic mechanism of cherubism
Noam Levaot, Oleksandr Voytyuk, Ioannis Dimitriou, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
December 11, 2014
The calcineurin inhibitor tacrolimus as a new therapy in severe cherubism
Natacha Kadlub, Marie-Paule Vazquez, Louise Galmiche, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 57) with videos related to
Sort By:
Page
of 6
Cellular and Molecular Gastroenterology and Hepatology
|
August 19, 2021
SYK-3BP2 Pathway Activity in Parenchymal and Myeloid Cells Is a Key Pathogenic Factor in Metabolic Steatohepatitis
Carmelo Luci, Elodie Vieira, Manon Bourinet, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
December 30, 2024
Disrupting USP39 deubiquitinase function impairs the survival and migration of multiple myeloma cells through ZEB1 degradation
Jessy Sirera, Saharnaz Sarlak, Manon Teisseire, et al.
The Journal of Experimental Medicine
|
September 28, 2011
The p.Arg63Trp polymorphism controls Vav1 functions and Foxp3 regulatory T cell development
Céline Colacios, Audrey Casemayou, Anne S Dejean, et al.
Plos One
|
August 23, 2012
The epithelial-mesenchymal transition (EMT) regulatory factor SLUG (SNAI2) is a downstream target of SPARC and AKT in promoting melanoma cell invasion
Nina Fenouille, Mélanie Tichet, Maeva Dufies, et al.
Iscience
|
February 25, 2025
Evolutionary conserved regulation of TFEB stability by the E3 ubiquitin ligase WWP2 modulates response to stress <i>in vivo</i>
Juan A Garcia-Sanchez, Estelle Bonnet, Céline Loubatier, et al.
Cancer Research
|
May 3, 2022
Secretion of IL1 by Dedifferentiated Melanoma Cells Inhibits JAK1-STAT3-Driven Actomyosin Contractility of Lymph Node Fibroblastic Reticular Cells
Christopher Rovera, Ilona Berestjuk, Margaux Lecacheur, et al.
Cancer Research
|
March 11, 2010
Targeting cancer cell metabolism: the combination of metformin and 2-deoxyglucose induces p53-dependent apoptosis in prostate cancer cells
Issam Ben Sahra, Kathiane Laurent, Sandy Giuliano, et al.
Human Pathology
|
August 8, 2016
Defining a new aggressiveness classification and using NFATc1 localization as a prognostic factor in cherubism
Natacha Kadlub, Quentin Sessiecq, Linda Dainese, et al.
Cell
|
December 14, 2011
Loss of Tankyrase-mediated destruction of 3BP2 is the underlying pathogenic mechanism of cherubism
Noam Levaot, Oleksandr Voytyuk, Ioannis Dimitriou, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
December 11, 2014
The calcineurin inhibitor tacrolimus as a new therapy in severe cherubism
Natacha Kadlub, Marie-Paule Vazquez, Louise Galmiche, et al.
Page
of 6